Table 3.
Perioperative outcomes in clinical series consisting of patients who underwent RARP after prostate surgery.
| Series | Study population | Mean follow-up, mos | Mean EBL, mL | Mean OR time, min | Mean days on catheter, d | Mean hospital stay, d | Nerve sparing, n |
|---|---|---|---|---|---|---|---|
| Zugor et al. [38] | 80 pts with TURP before RARP versus 80 pts with RARP | 13.5 | 165 versus 144 | 189 versus 149 | 6.8 versus 5.2 | NA | 42 versus 54 |
| Martin et al. [36] |
24 pts with previous treatment to the prostate and RARP versus 486 with no previous treatment and RARP | NA | 155 versus 137 | 200 versus 186 | 12 versus 8 (P = 0.028) | 2.2 versus 1.5 | 14 versus 403 |
| Gupta et al. [37] |
18 pts with TURP before RARP versus 8 pts with pT1b CaP and RARP versus 132 pts with RARP | 15.3 | 4941 versus 358.3 versus 324.2 (P = 0.03) | 189.1 versus 162.5 versus 166 | 15.5 versus 14.2 versus 13.3 | 4.4 versus 4.1 versus 3.2 | NA |
| Martin- schek et al. [39] |
19 pts with previous TURP and RARP versus 19 pts with previous TURP and RRP | NA | 333 versus 1103 (P < 0.001) | 217 versus 174 (P = 0.02) | 7.9 versus 11.7 (P = 0.001) | 8.5 versus 11.7 (P = 0.003) | 14 versus 13 |
TURP: transurethral resection of the prostate; RARP: robot-assisted radical prostatectomy; CaP: prostate cancer; EBL: estimated blood loss; OR: operating; and NA: not available.